LXEO
Lexeo Therapeutics, Inc.
Company overview
- Market capitalization
- $257.63M
- Employees
- 59
- Latest publication
- 2026-09-29
About Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc., a clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States. Its product pipeline comprises LX2006, an AAVrh10-based gene therapy candidate, which is in phase 1/2 clinical trial to treat friedreich ataxia cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate, which is in phase 1/2 to deliver a functional plakophilin-2 (PKP2) gene to cardiac muscle for the treatment of PKP2-ACM; and LX2021, a gene therapy candidate, which is in preclinical trial to deliver the coding sequence for the functional connexin 43, or Cx43, protein for a group of inherited cardiac muscle disorders associated with a high risk of sudden death, including arrhythmogenic cardiomyopathy (ACM) and certain forms of dilated cardiomyopathy. The company is also developing LX2022, a gene therapy candidate, which is in preclinical trial to deliver a functional TNNI3 gene to myocardial cells to treat a distinct form of hypertrophic cardiomyopathy. In addition, it is developing LX1001, LX1020, and LX1021, an AAVrh10-based gene therapy candidate, which has completed phase 1/2 clinical trial for the treatment of APOE4-associated Alzheimer's disease. The company has a license agreement with Cornell University to conduct the Phase 1/2 clinical trial of LX1001, as well as support the development of the LX1004 program; a research collaboration agreement with Cornell University to conduct preclinical research to develop the licensed technology; and third license agreement which obtained certain rights for FA cardiomyopathy, including rights to current and future clinical data from an ongoing Cornell University investigator-initiated Phase 1A trial of a gene therapy candidate. The company was founded in 2017 and is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 1,944,000USD | 0USD | 0USD |
| Cost Of Revenue | 546,000USD | 538,000USD | 530,000USD | 510,000USD | 501,000USD | — | 509,000USD | 496,000USD |
| Gross Profit | -546,000USD | -538,000USD | -530,000USD | -510,000USD | -501,000USD | 972,000USD | -509,000USD | -496,000USD |
| Research Development | 15,703,000USD | 16,210,000USD | 15,695,000USD | 14,721,000USD | 17,171,000USD | 18,366,000USD | 23,423,000USD | 16,560,000USD |
| Selling General Administrative | 6,630,000USD | 6,906,000USD | 5,953,000USD | 15,967,000USD | 16,634,000USD | 9,016,000USD | 8,120,000USD | 6,990,000USD |
| Total Operating Expenses | 21,787,000USD | 23,116,000USD | 21,648,000USD | 30,688,000USD | 33,805,000USD | 27,382,000USD | 31,543,000USD | 23,550,000USD |
| Operating Income | -22,333,000USD | -23,116,000USD | -21,648,000USD | -30,688,000USD | -33,805,000USD | -27,382,000USD | -31,543,000USD | -23,550,000USD |
| Interest Income | 2,155,000USD | 2,213,000USD | 1,456,000USD | 1,268,000USD | 1,193,000USD | 1,488,000USD | 2,092,000USD | 2,348,000USD |
| Interest Expense | 17,000USD | 25,000USD | 82,000USD | 59,000USD | 40,000USD | 30,000USD | 35,000USD | 35,000USD |
| Net Interest Income | 2,138,000USD | 2,188,000USD | 1,374,000USD | 1,209,000USD | 1,153,000USD | 1,458,000USD | 2,057,000USD | 2,313,000USD |
| Income Before Tax | -20,196,000USD | -20,919,000USD | -20,283,000USD | -26,103,000USD | -32,656,000USD | -25,924,000USD | -29,489,000USD | -21,238,000USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income | -20,196,000USD | -20,919,000USD | -20,283,000USD | -26,103,000USD | -32,656,000USD | -25,924,000USD | -29,489,000USD | -21,238,000USD |
| Net Income From Continuing Ops | -20,196,000USD | -20,919,000USD | -20,283,000USD | -26,103,000USD | -32,656,000USD | -25,924,000USD | -29,489,000USD | -21,238,000USD |
| Ebit | -22,333,000USD | -20,894,000USD | -20,201,000USD | -26,044,000USD | -32,616,000USD | -25,894,000USD | -29,454,000USD | -21,203,000USD |
| Ebitda | -21,787,000USD | -20,356,000USD | -19,671,000USD | -25,534,000USD | -32,115,000USD | -25,373,000USD | -28,945,000USD | -20,707,000USD |
| Depreciation And Amortization | 546,000USD | 538,000USD | 530,000USD | 510,000USD | 501,000USD | 521,000USD | 509,000USD | 496,000USD |
| Reconciled Depreciation | 546,000USD | 538,000USD | 530,000USD | 510,000USD | 501,000USD | 521,000USD | 509,000USD | 496,000USD |
| Total Other Income Expense Net | 2,137,000USD | 2,197,000USD | 1,365,000USD | 4,585,000USD | 1,149,000USD | 1,458,000USD | 2,054,000USD | 2,312,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 496,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 654,000USD | 1,657,000USD | 518,476USD |
| Cost Of Revenue | 2,079,000USD | 2,001,999USD | 1,843,000USD | 1,145,000USD | 13,405USD | — |
| Gross Profit | -2,079,000USD | -2,001,999USD | -1,843,000USD | 654,000USD | 1,657,000USD | 518,476USD |
| Research Development | 63,797,000USD | 74,091,000USD | 53,130,000USD | 49,162,000USD | 45,121,000USD | 4,318,765USD |
| Selling General Administrative | 45,460,000USD | 31,675,000USD | 15,383,000USD | 12,001,000USD | 7,173,000USD | 787,499USD |
| Total Operating Expenses | 109,257,000USD | 105,766,000USD | 68,513,000USD | 61,163,000USD | 52,294,000USD | 5,106,264USD |
| Operating Income | -109,257,000USD | -105,766,000USD | -68,513,000USD | -60,509,000USD | -50,637,000USD | -4,587,788USD |
| Interest Income | 6,130,000USD | 7,579,000USD | 2,867,000USD | 1,325,000USD | 15,000USD | — |
| Interest Expense | 206,000USD | 114,000USD | 205,000USD | 91,000USD | 0USD | 147,150USD |
| Net Interest Income | 5,924,000USD | 7,442,000USD | 2,662,000USD | 1,234,000USD | 15,000USD | -147,150USD |
| Income Before Tax | -99,961,000USD | -98,333,000USD | -66,394,000USD | -59,277,000USD | -50,622,000USD | -5,152,788USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income | -99,961,000USD | -98,333,000USD | -66,394,000USD | -59,277,000USD | -50,622,000USD | -5,152,788USD |
| Net Income From Continuing Ops | -99,961,000USD | -98,333,000USD | -66,394,000USD | -59,277,000USD | -50,622,000USD | -5,152,788USD |
| Ebit | -99,755,000USD | -98,196,000USD | -66,189,000USD | -59,186,000USD | -50,622,000USD | -4,587,788USD |
| Ebitda | -97,676,000USD | -96,194,000USD | -64,346,000USD | -58,041,000USD | -50,609,000USD | -4,587,788USD |
| Depreciation And Amortization | 2,079,000USD | 2,002,000USD | 1,843,000USD | 1,145,000USD | 13,000USD | 4,241USD |
| Reconciled Depreciation | 2,079,000USD | 2,002,000USD | 1,843,000USD | 1,145,000USD | 13,000USD | 0USD |
| Total Other Income Expense Net | 9,296,000USD | 7,433,000USD | 2,119,000USD | 1,232,000USD | 15,000USD | -565,000USD |
| Income Tax Expense | — | — | -1USD | 89,000USD | -155USD | 147,150USD |
| Selling And Marketing Expenses | — | — | — | — | 13,379USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 254,898,000USD | 250,356,000USD | 268,688,000USD | 143,844,000USD | 176,068,000USD | 125,690,000USD | 146,942,000USD | 173,865,000USD |
| Cash And Equivalents | 92,834,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 217,908,000USD | 200,862,000USD | 188,392,000USD | 127,793,000USD | 140,062,000USD | 105,274,000USD | 126,121,000USD | 159,458,000USD |
| Other Current Assets | 6,205,000USD | 129,094,000USD | 6,625,000USD | 86,797,000USD | 7,169,000USD | 5,443,000USD | 4,603,000USD | 2,438,000USD |
| Total Liabilities | 19,837,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 15,692,000USD | 14,189,000USD | 16,808,000USD | 17,271,000USD | 31,593,000USD | 30,823,000USD | 22,846,000USD | 26,818,000USD |
| Total Stockholder Equity | 235,061,000USD | 231,497,000USD | 246,669,000USD | 120,831,000USD | 138,218,000USD | 88,115,000USD | 116,842,000USD | 139,326,000USD |
| Total Equity Including Noncontrolling Interest | 235,061,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 6,904,000USD | 8,346,000USD | 8,857,000USD | 9,413,000USD | 9,755,000USD | 10,133,000USD | 10,557,000USD | 11,155,000USD |
| Accounts Payable | 4,179,000USD | 3,335,000USD | 4,856,000USD | 4,656,000USD | 20,025,000USD | 11,981,000USD | 6,417,000USD | 8,438,000USD |
| Short Term Debt | 2,177,000USD | 2,695,000USD | 2,675,000USD | 2,715,000USD | 2,656,000USD | 2,647,000USD | 2,670,000USD | 2,682,000USD |
| Common Stock | 8,000USD | 7,000USD | 7,000USD | 5,000USD | 5,000USD | 3,000USD | 3,000USD | 3,000USD |
| Retained Earnings | -426,197,000USD | -400,330,000USD | -380,134,000USD | -359,215,000USD | -338,932,000USD | -312,829,000USD | -280,173,000USD | -254,249,000USD |
| Accumulated Other Comprehensive Income | -298,000USD | -142,000USD | 188,000USD | 89,000USD | -13,000USD | -54,000USD | -103,000USD | — |
| Total Liab | — | 18,859,000USD | 22,019,000USD | 23,013,000USD | 37,850,000USD | 37,575,000USD | 30,100,000USD | 34,539,000USD |
| Other Current Liab | — | 8,159,000USD | 9,277,000USD | 9,900,000USD | 8,912,000USD | 16,195,000USD | 13,759,000USD | 15,698,000USD |
| Capital Stock | — | 7,000USD | 7,000USD | 5,000USD | 5,000USD | 3,000USD | 3,000USD | 3,000USD |
| Cash | — | 71,768,000USD | 63,000,000USD | 40,996,000USD | 35,480,000USD | 28,913,000USD | 35,014,000USD | 157,020,000USD |
| Cash And Short Term Investments | — | 71,768,000USD | 181,767,000USD | 40,996,000USD | 132,893,000USD | 99,831,000USD | 121,518,000USD | 157,020,000USD |
| Net Debt | — | -64,403,000USD | -55,114,000USD | -32,539,000USD | -26,567,000USD | -19,514,000USD | -25,090,000USD | -146,617,000USD |
| Short Long Term Debt Total | — | 7,365,000USD | 7,886,000USD | 8,457,000USD | 8,913,000USD | 9,399,000USD | 9,924,000USD | 10,403,000USD |
| Long Term Investments | — | 37,900,000USD | 68,191,000USD | 3,390,000USD | 23,003,000USD | 7,035,000USD | 7,012,000USD | — |
| Short Term Investments | — | 121,275,000USD | 118,767,000USD | 81,768,000USD | 97,413,000USD | 70,918,000USD | 86,504,000USD | — |
| Property Plant Equipment Gross | — | 9,160,000USD | 9,598,000USD | 10,081,000USD | 10,351,000USD | 10,667,000USD | 11,031,000USD | 11,765,000USD |
| Common Stock Shares Outstanding | — | 81,183,812shares | 76,356,996shares | 60,980,867shares | 43,573,628shares | 33,113,991shares | 33,076,093shares | 33,063,153shares |
| Non Current Assets Total | — | 49,494,000USD | 80,296,000USD | 16,051,000USD | 36,006,000USD | 20,416,000USD | 20,821,000USD | 14,407,000USD |
| Non Current Liabilities Total | — | 4,670,000USD | 5,211,000USD | 5,742,000USD | 6,257,000USD | 6,752,000USD | 7,254,000USD | 7,721,000USD |
| Non Currrent Assets Other | — | 6,638,000USD | 6,638,000USD | 6,638,000USD | 3,248,000USD | 3,248,000USD | 274,000USD | 3,252,000USD |
| Net Working Capital | — | 186,673,000USD | 171,584,000USD | 110,522,000USD | 108,469,000USD | 74,451,000USD | 103,275,000USD | 132,640,000USD |
| Unclassified Current Assets | — | -121,275,000USD | — | -81,768,000USD | — | — | — | — |
| Unclassified Non Current Assets | — | -3,390,000USD | -3,390,000USD | -3,390,000USD | — | — | 2,978,000USD | — |
| Unclassified Non Current Liabilities | — | 4,670,000USD | 5,211,000USD | 5,742,000USD | 6,257,000USD | 6,752,000USD | 7,254,000USD | 7,721,000USD |
| Unclassified Equity | — | 631,955,000USD | 626,601,000USD | 479,947,000USD | 477,153,000USD | 400,992,000USD | 397,112,000USD | 393,569,000USD |
| Other Assets | — | — | — | — | — | — | -2,978,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 268,688,000USD | 146,942,000USD | 139,807,000USD | 97,076,000USD | 136,860,000USD | 29,409,281USD |
| Other Current Assets | 6,625,000USD | 4,603,000USD | 2,828,000USD | 2,713,000USD | 824,000USD | 33,572USD |
| Total Liab | 22,019,000USD | 30,100,000USD | 26,272,000USD | 210,030,000USD | 192,462,000USD | 34,945,708USD |
| Total Stockholder Equity | 246,669,000USD | 116,842,000USD | 113,535,000USD | -112,954,000USD | -55,602,000USD | -5,536,427USD |
| Other Current Liab | 9,277,000USD | 13,759,000USD | 10,683,000USD | 8,331,000USD | 3,814,000USD | 474,715USD |
| Common Stock | 7,000USD | 3,000USD | 3,000USD | 2,000USD | 1,675USD | 1,604USD |
| Capital Stock | 7,000USD | 3,000USD | 3,000USD | 2,000USD | 2,000USD | 1,604USD |
| Retained Earnings | -380,134,000USD | -280,173,000USD | -181,840,000USD | -115,446,000USD | -56,169,538USD | -5,547,825USD |
| Cash | 63,000,000USD | 35,014,000USD | 121,466,000USD | 77,335,000USD | 135,860,000USD | 29,373,209USD |
| Cash And Short Term Investments | 181,767,000USD | 121,518,000USD | 121,466,000USD | 77,335,000USD | 135,860,000USD | 29,373,209USD |
| Total Current Assets | 188,392,000USD | 126,121,000USD | 124,294,000USD | 80,048,000USD | 136,684,000USD | 29,406,781USD |
| Total Current Liabilities | 16,808,000USD | 22,846,000USD | 17,239,000USD | 14,349,000USD | 7,449,000USD | 697,722USD |
| Net Debt | -55,114,000USD | -25,090,000USD | -109,828,000USD | -63,853,000USD | -135,860,000USD | -29,373,209USD |
| Short Term Debt | 2,675,000USD | 2,670,000USD | 2,605,000USD | 2,834,000USD | 4,312,000USD | 513,019USD |
| Short Long Term Debt Total | 7,886,000USD | 9,924,000USD | 11,638,000USD | 13,482,000USD | — | 3,010,000USD |
| Long Term Investments | 68,191,000USD | 7,012,000USD | 0USD | — | — | — |
| Short Term Investments | 118,767,000USD | 86,504,000USD | 0USD | — | — | — |
| Accounts Payable | 4,856,000USD | 6,417,000USD | 3,794,000USD | 2,678,000USD | 3,061,000USD | 44,319USD |
| Property Plant Equipment Net | 8,857,000USD | 10,557,000USD | 12,261,000USD | 13,775,000USD | 174,000USD | 0USD |
| Property Plant Equipment Gross | 9,598,000USD | 11,031,000USD | 12,642,000USD | 13,908,000USD | 187,000USD | 0USD |
| Accumulated Other Comprehensive Income | 188,000USD | -103,000USD | -139,807,000USD | -185,033,000USD | -185,012,970USD | -31,237,986USD |
| Common Stock Shares Outstanding | 53,645,323shares | 31,787,491shares | 26,646,378shares | 25,169,328shares | 25,169,328shares | 25,169,328shares |
| Non Current Assets Total | 80,296,000USD | 20,821,000USD | 15,513,000USD | 21,260,000USD | 176,000USD | 2,500USD |
| Non Current Liabilities Total | 5,211,000USD | 7,254,000USD | 9,033,000USD | 195,681,000USD | 185,013,000USD | 34,247,986USD |
| Non Currrent Assets Other | 6,638,000USD | 3,252,000USD | 3,252,000USD | 7,485,000USD | 2,000USD | 2,500USD |
| Net Working Capital | 171,584,000USD | 103,275,000USD | 107,055,000USD | 65,699,000USD | 129,235,000USD | 28,709,059USD |
| Unclassified Non Current Assets | -3,390,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | 5,211,000USD | 7,254,000USD | 9,033,000USD | 195,681,000USD | 185,013,000USD | 34,247,986USD |
| Unclassified Equity | 626,601,000USD | 397,112,000USD | 435,176,000USD | 187,521,000USD | 185,576,833USD | 31,246,176USD |
| Current Deferred Revenue | — | — | 10,671,000USD | 8,597,000USD | 46,000USD | 140,384USD |
| Unclassified Current Liabilities | — | — | -10,514,000USD | -8,091,000USD | -3,784,000USD | — |
| Other Assets | — | — | — | -4,232,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 147,000USD |
| Stock Based Compensation | 8,445,000USD |
| Change To Liabilities | -1,171,000USD |
| Change In Working Capital | -989,000USD |
| Operating Cash Flow | -38,741,000USD |
| Capital Expenditures | -42,000USD |
| Net Investments | 41,766,000USD |
| Investing Cash Flow | 41,724,000USD |
| Net Debt Issuance | -263,000USD |
| Unclassified Financing Cash Flow | 27,114,000USD |
| Financing Cash Flow | 26,851,000USD |
| Change In Cash | 29,834,000USD |
| End Cash Flow | 96,082,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -20,196,000USD | -20,919,000USD | -20,283,000USD | -26,103,000USD | -32,656,000USD | -25,924,000USD | -29,489,000USD | -21,238,000USD |
| Depreciation | 31,000USD | 921,000USD | 530,000USD | 510,000USD | 501,000USD | 521,000USD | 509,000USD | 496,000USD |
| Stock Based Compensation | 2,755,000USD | 2,713,000USD | 2,651,000USD | 3,071,000USD | 3,697,000USD | 3,507,000USD | 3,790,000USD | 2,846,000USD |
| Other Non Cash Items | 473,000USD | -395,000USD | 60,000USD | -3,356,000USD | 12,000USD | -23,000USD | 10,388,000USD | 2,779,000USD |
| Change In Working Capital | -4,207,000USD | -2,399,000USD | -12,505,000USD | -1,341,000USD | 6,730,000USD | -6,407,000USD | 7,384,000USD | -2,256,000USD |
| Total Cash From Operating Activities | -21,144,000USD | -20,079,000USD | -29,547,000USD | -27,219,000USD | -21,716,000USD | -28,326,000USD | -17,806,000USD | -20,152,000USD |
| Capital Expenditures | -35,000USD | 0USD | -289,000USD | -108,000USD | 0USD | -13,000USD | -83,000USD | -218,000USD |
| Free Cash Flow | -21,179,000USD | -20,079,000USD | -29,836,000USD | -27,327,000USD | -21,716,000USD | -28,313,000USD | -17,889,000USD | -20,370,000USD |
| Investments | 27,495,000USD | -101,689,000USD | 35,011,000USD | -39,174,000USD | 15,600,000USD | -93,583,000USD | -83,000USD | -218,000USD |
| Total Cashflows From Investing Activities | 27,460,000USD | -101,689,000USD | 35,011,000USD | -39,174,000USD | 15,600,000USD | -93,583,000USD | -83,000USD | -218,000USD |
| Net Borrowings | -121,000USD | -169,000USD | -83,000USD | -122,000USD | -159,000USD | -116,000USD | -111,000USD | — |
| Total Cash From Financing Activities | 2,452,000USD | 143,772,000USD | 52,000USD | 72,960,000USD | 11,000USD | -97,000USD | -72,000USD | 291,000USD |
| Issuance Of Capital Stock | 143,000USD | 153,749,000USD | 101,000USD | 79,999,000USD | 170,000USD | 0USD | -6,287,000USD | -41,000USD |
| Change In Cash | 8,768,000USD | 22,004,000USD | 5,516,000USD | 6,567,000USD | -6,105,000USD | -122,006,000USD | -17,961,000USD | -20,079,000USD |
| Begin Period Cash Flow | 66,248,000USD | 44,244,000USD | 38,728,000USD | 32,161,000USD | 38,266,000USD | 157,020,000USD | 178,233,000USD | 195,060,000USD |
| End Period Cash Flow | 75,016,000USD | 66,248,000USD | 44,244,000USD | 38,728,000USD | 32,161,000USD | 35,014,000USD | 160,272,000USD | 174,981,000USD |
| Other Cashflows From Financing Activities | 2,452,000USD | 143,772,000USD | 34,000USD | -6,917,000USD | — | 23,000USD | 6,326,000USD | 419,000USD |
| Sale Purchase Of Stock | — | -79,999,000USD | 79,999,000USD | — | — | -4,000USD | 13,000USD | -13,000USD |
| Other Cashflows From Investing Activities | — | 17,000USD | — | — | — | -93,583,000USD | -13,000USD | -5,000USD |
| Unclassified Financing Cash Flow | — | 80,168,000USD | -79,898,000USD | — | — | — | -6,300,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | 93,596,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -10,388,000USD | -2,779,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -99,961,000USD | -98,333,000USD | -66,394,000USD | -59,277,000USD | -50,622,000USD | -5,152,788USD |
| Depreciation | 379,000USD | 2,001,999USD | 1,843,000USD | 1,145,000USD | 13,000USD | 0USD |
| Stock Based Compensation | 12,132,000USD | 12,474,000USD | 3,043,000USD | 1,781,000USD | 386,000USD | 0USD |
| Other Non Cash Items | -1,596,000USD | -22,999USD | 530,000USD | 4,497,000USD | -692USD | 1,869,241USD |
| Change In Working Capital | -9,515,000USD | 2,729,000USD | 1,482,000USD | 1,791,000USD | 6,041,000USD | 150,151USD |
| Total Cash From Operating Activities | -98,561,000USD | -81,151,000USD | -59,496,000USD | -54,560,000USD | -44,182,000USD | -3,133,396USD |
| Capital Expenditures | -397,000USD | -481,000USD | -165,000USD | -901,000USD | -188,000USD | 0USD |
| Free Cash Flow | -98,958,000USD | -81,632,000USD | -59,661,000USD | -55,461,000USD | -44,370,000USD | -3,133,396USD |
| Investments | -89,855,000USD | -94,077,000USD | -165,000USD | -901,000USD | -188,000USD | 0USD |
| Total Cashflows From Investing Activities | -90,252,000USD | -94,077,000USD | -165,000USD | -901,000USD | -188,000USD | — |
| Net Borrowings | -533,000USD | -410,000USD | 3,575,000USD | -163,000USD | 0USD | — |
| Total Cash From Financing Activities | 216,795,000USD | 88,776,000USD | 103,791,000USD | 189,000USD | 150,857,000USD | 32,378,745USD |
| Sale Purchase Of Stock | 79,999,000USD | -17,000USD | 0USD | — | — | — |
| Issuance Of Capital Stock | 234,019,000USD | 88,712,000USD | 100,251,000USD | 20,000USD | 151,060,000USD | 29,999,996USD |
| Change In Cash | 27,982,000USD | -86,452,000USD | 44,130,000USD | -55,272,000USD | 106,487,000USD | 29,245,349USD |
| Begin Period Cash Flow | 38,266,000USD | 124,718,000USD | 80,588,000USD | 135,860,000USD | 29,373,000USD | 127,860USD |
| End Period Cash Flow | 66,248,000USD | 38,266,000USD | 124,718,000USD | 80,588,000USD | 135,860,000USD | 29,373,209USD |
| Other Cashflows From Investing Activities | 17,000USD | — | -50,000USD | -229,000USD | — | — |
| Other Cashflows From Financing Activities | 216,795,000USD | 491,000USD | -35,000USD | 352,000USD | 150,857,000USD | 29,776,409USD |
| Unclassified Financing Cash Flow | -79,466,000USD | 88,712,000USD | 100,251,000USD | — | -151,060,000USD | -27,397,660USD |
| Unclassified Operating Cash Flow | — | — | — | -4,497,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | 1,130,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.